EVERSPIN TECHNOLOGIES INC (MRAM) Fundamental Analysis & Valuation

NASDAQ:MRAM • US30041T1043

8.76 USD
-0.36 (-3.89%)
At close: Mar 6, 2026
8.75 USD
-0.01 (-0.11%)
After Hours: 3/6/2026, 8:00:02 PM

This MRAM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MRAM. MRAM was compared to 115 industry peers in the Semiconductors & Semiconductor Equipment industry. While MRAM has a great health rating, there are worries on its profitability. MRAM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. MRAM Profitability Analysis

1.1 Basic Checks

  • In the past year MRAM was profitable.
  • In the past year MRAM had a positive cash flow from operations.
  • MRAM had positive earnings in 4 of the past 5 years.
  • MRAM had a positive operating cash flow in each of the past 5 years.
MRAM Yearly Net Income VS EBIT VS OCF VS FCFMRAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M

1.2 Ratios

  • MRAM has a Return On Assets of -0.71%. This is comparable to the rest of the industry: MRAM outperforms 46.09% of its industry peers.
  • MRAM has a Return On Equity of -0.86%. This is comparable to the rest of the industry: MRAM outperforms 46.09% of its industry peers.
Industry RankSector Rank
ROA -0.71%
ROE -0.86%
ROIC N/A
ROA(3y)8.51%
ROA(5y)2.08%
ROE(3y)11.3%
ROE(5y)0.19%
ROIC(3y)N/A
ROIC(5y)N/A
MRAM Yearly ROA, ROE, ROICMRAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • MRAM's Profit Margin has declined in the last couple of years.
  • MRAM's Gross Margin of 51.31% is fine compared to the rest of the industry. MRAM outperforms 65.22% of its industry peers.
  • MRAM's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for MRAM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.82%
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.18%
MRAM Yearly Profit, Operating, Gross MarginsMRAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

8

2. MRAM Health Analysis

2.1 Basic Checks

  • MRAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MRAM has more shares outstanding
  • MRAM has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for MRAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MRAM Yearly Shares OutstandingMRAM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
MRAM Yearly Total Debt VS Total AssetsMRAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • MRAM has an Altman-Z score of 7.44. This indicates that MRAM is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 7.44, MRAM is doing good in the industry, outperforming 66.09% of the companies in the same industry.
  • There is no outstanding debt for MRAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.44
ROIC/WACCN/A
WACC11.18%
MRAM Yearly LT Debt VS Equity VS FCFMRAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • MRAM has a Current Ratio of 5.84. This indicates that MRAM is financially healthy and has no problem in meeting its short term obligations.
  • MRAM has a better Current ratio (5.84) than 76.52% of its industry peers.
  • MRAM has a Quick Ratio of 4.81. This indicates that MRAM is financially healthy and has no problem in meeting its short term obligations.
  • MRAM has a Quick ratio of 4.81. This is in the better half of the industry: MRAM outperforms 74.78% of its industry peers.
Industry RankSector Rank
Current Ratio 5.84
Quick Ratio 4.81
MRAM Yearly Current Assets VS Current LiabilitesMRAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

3

3. MRAM Growth Analysis

3.1 Past

  • The earnings per share for MRAM have decreased strongly by -32.72% in the last year.
  • MRAM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.94% yearly.
EPS 1Y (TTM)-32.72%
EPS 3Y-23.94%
EPS 5YN/A
EPS Q2Q%-5.98%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.76%

3.2 Future

  • MRAM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.58% yearly.
  • Based on estimates for the next years, MRAM will show a quite strong growth in Revenue. The Revenue will grow by 8.86% on average per year.
EPS Next Y40.48%
EPS Next 2Y6.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.39%
Revenue Next 2Y8.86%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
MRAM Yearly Revenue VS EstimatesMRAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
MRAM Yearly EPS VS EstimatesMRAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3 -4

3

4. MRAM Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 39.82, the valuation of MRAM can be described as expensive.
  • 70.43% of the companies in the same industry are more expensive than MRAM, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.29, MRAM is valued quite expensively.
  • The Price/Forward Earnings ratio is 28.34, which means the current valuation is very expensive for MRAM.
  • MRAM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MRAM is cheaper than 67.83% of the companies in the same industry.
  • MRAM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 39.82
Fwd PE 28.34
MRAM Price Earnings VS Forward Price EarningsMRAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, MRAM is valued a bit cheaper than 71.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.81
EV/EBITDA N/A
MRAM Per share dataMRAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • MRAM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.98
PEG (5Y)N/A
EPS Next 2Y6.58%
EPS Next 3YN/A

0

5. MRAM Dividend Analysis

5.1 Amount

  • No dividends for MRAM!.
Industry RankSector Rank
Dividend Yield 0%

MRAM Fundamentals: All Metrics, Ratios and Statistics

EVERSPIN TECHNOLOGIES INC

NASDAQ:MRAM (3/6/2026, 8:00:02 PM)

After market: 8.75 -0.01 (-0.11%)

8.76

-0.36 (-3.89%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)03-04
Earnings (Next)04-28
Inst Owners62.94%
Inst Owner Change10.18%
Ins Owners5.02%
Ins Owner Change-2.02%
Market Cap200.25M
Revenue(TTM)N/A
Net Income(TTM)-568.00K
Analysts82.5
Price Target13.01 (48.52%)
Short Float %2.99%
Short Ratio0.86
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.18%
Min EPS beat(2)17.65%
Max EPS beat(2)30.72%
EPS beat(4)4
Avg EPS beat(4)336.68%
Min EPS beat(4)17.65%
Max EPS beat(4)1207.19%
EPS beat(8)8
Avg EPS beat(8)401.03%
EPS beat(12)12
Avg EPS beat(12)293.44%
EPS beat(16)16
Avg EPS beat(16)625.95%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)-0.44%
Revenue beat(4)2
Avg Revenue beat(4)1.23%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)3.87%
Revenue beat(8)4
Avg Revenue beat(8)0.67%
Revenue beat(12)8
Avg Revenue beat(12)1.3%
Revenue beat(16)12
Avg Revenue beat(16)1.75%
PT rev (1m)21.43%
PT rev (3m)21.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)7.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 39.82
Fwd PE 28.34
P/S 3.73
P/FCF 42.81
P/OCF 17.93
P/B 3.04
P/tB 3.14
EV/EBITDA N/A
EPS(TTM)0.22
EY2.51%
EPS(NY)0.31
Fwd EY3.53%
FCF(TTM)0.2
FCFY2.34%
OCF(TTM)0.49
OCFY5.58%
SpS2.35
BVpS2.88
TBVpS2.79
PEG (NY)0.98
PEG (5Y)N/A
Graham Number3.78
Profitability
Industry RankSector Rank
ROA -0.71%
ROE -0.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.31%
FCFM 8.72%
ROA(3y)8.51%
ROA(5y)2.08%
ROE(3y)11.3%
ROE(5y)0.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.82%
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.18%
F-Score3
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 209.73%
Cap/Sales 12.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.84
Quick Ratio 4.81
Altman-Z 7.44
F-Score3
WACC11.18%
ROIC/WACCN/A
Cap/Depr(3y)192.66%
Cap/Depr(5y)132.94%
Cap/Sales(3y)4.31%
Cap/Sales(5y)3.11%
Profit Quality(3y)251.99%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.72%
EPS 3Y-23.94%
EPS 5YN/A
EPS Q2Q%-5.98%
EPS Next Y40.48%
EPS Next 2Y6.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.76%
Revenue Next Year9.39%
Revenue Next 2Y8.86%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-77.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1162.5%
EBIT Next 3Y181.26%
EBIT Next 5YN/A
FCF growth 1Y-66.03%
FCF growth 3Y-21.44%
FCF growth 5YN/A
OCF growth 1Y-31.56%
OCF growth 3Y-8.8%
OCF growth 5YN/A

EVERSPIN TECHNOLOGIES INC / MRAM FAQ

Can you provide the ChartMill fundamental rating for EVERSPIN TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 4 / 10 to MRAM.


What is the valuation status for MRAM stock?

ChartMill assigns a valuation rating of 3 / 10 to EVERSPIN TECHNOLOGIES INC (MRAM). This can be considered as Overvalued.


Can you provide the profitability details for EVERSPIN TECHNOLOGIES INC?

EVERSPIN TECHNOLOGIES INC (MRAM) has a profitability rating of 3 / 10.


Can you provide the financial health for MRAM stock?

The financial health rating of EVERSPIN TECHNOLOGIES INC (MRAM) is 8 / 10.